Guerbet highlights gadopiclenol MRI contrast agent at RSNA

At previous RSNA, Guerbet showcased its gadopiclenol contrast agent (Elucirem) for MRI. On November 29, the company will present safety data for Elucirem in an abstract titled “Safety of gadopiclenol for magnetic resonance imaging (MRI): a pooled analysis of eight studies.”

In addition to Elucirem, Guerbet will highlight the following offerings at its booth:

* Dose and Care: Software for monitoring patient exposure to X-rays
* Contrast and Care: Injection data management software for imaging centers
* Icobrain: Cloud-based AI solution for quantifying disease-specific brain structures on MRI and CT imaging
* Galileo: Educational web-based case review platform for radiology resident training
* Myrian: Image processing software for integration into healthcare information systems
* Optistar Elite: Dual-head contrast delivery system with an ultrasonic motor (nonmagnetic)